The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The Duke-Margolis Center for Health Policy has marshalled its outstanding network of experts to respond to the crisis in real time, guiding Federal and state leaders through this extraordinarily difficult period. Interdisciplinary faculty and researchers from Duke University, Duke Health System and other leading health organizations are collaborating on vital, evidence-based strategies needed now to address the pandemic.

Duke-Margolis has put forward key policy steps leaders must take to respond comprehensively to the COVID-19 pandemic, to reopen the nation successfully, and create a more secure health care system. At the same time, the Center continues its vital mission to educate tomorrow’s health policy leaders, develop and analyze new data, provide timely thought leadership, and engage the greater public through outreach and education.

Marc Lipsitch, Mark McClellan and Robert Rodriguez

Michelle Franklin, Christina Silcox, Rebecca Ray, Mira Gill, Ethan Bore, Susan Dentzer, Mark McClellan

This two-day public workshop will convene regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines. Participants will discuss epidemiological and abuse liability data, patient and clinician perspectives and experiences, and gaps in data and understanding about the safe use of benzodiazepines.

Amanda Glassman, J. Stephen Morrison, Gary Edson, Mark McClellan, Rachel Silverman, Katherine Bliss, John Bridgeland, Krishna Udayakumar, Prashant Yadav, Anna McCaffrey, Anjali Balakrishna, Michael Merson